找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bone Metastases from Prostate Cancer; Biology, Diagnosis a Francesco Bertoldo,Francesco Boccardo,Riccardo Val Book 2017 Springer Internatio

[復(fù)制鏈接]
樓主: CHORD
11#
發(fā)表于 2025-3-23 13:41:09 | 只看該作者
,Durchführung der Lithiumtherapie,synthesis, inhibitors of adrenal androgen synthesis, and first and second generation of antiandrogens. These agents exert a good control of the disease in terms of both overall survival and reduction in the incidence and severity of skeletal adverse events. In hormone-na?ve patients, luteinizing hor
12#
發(fā)表于 2025-3-23 17:51:04 | 只看該作者
13#
發(fā)表于 2025-3-23 21:07:53 | 只看該作者
14#
發(fā)表于 2025-3-24 01:24:52 | 只看該作者
15#
發(fā)表于 2025-3-24 03:29:39 | 只看該作者
Circulating Tumor Cells (CTCs) and Metastatic Prostate Cancer (mPCa),g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.
16#
發(fā)表于 2025-3-24 08:27:37 | 只看該作者
Book 2017respect to biology, pathology, diagnosis, and treatment are described, providing readers with an excellent understanding of the mechanisms of metastasis formation, the characteristics of metastases, their aggressiveness, and prognostic factors for treatment response. The coverage includes discussion
17#
發(fā)表于 2025-3-24 10:39:55 | 只看該作者
Preparations, Dosage, and Control,g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.
18#
發(fā)表于 2025-3-24 15:51:11 | 只看該作者
Studies in Human Ecology and Adaptationr PFS and OS than those with 5–20 BMTs [4]. It should, however, be taken into account that among the predictors of prognosis, coexisting non-osseous metastatic disease is an important determinant of prognosis in patients with BMTs [5, 6].
19#
發(fā)表于 2025-3-24 20:41:09 | 只看該作者
20#
發(fā)表于 2025-3-25 01:42:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 01:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新津县| 邵武市| 浦东新区| 车致| 革吉县| 海丰县| 洪湖市| 安丘市| 西峡县| 梅河口市| 连城县| 梓潼县| 淮滨县| 龙游县| 伊春市| 宝丰县| 稷山县| 酒泉市| 湟源县| 合川市| 嘉定区| 江源县| 潞西市| 丽水市| 茶陵县| 邯郸市| 元阳县| 肥东县| 崇义县| 怀柔区| 博罗县| 井陉县| 名山县| 恭城| 营山县| 谢通门县| 都昌县| 金乡县| 西和县| 吉安县| 嘉祥县|